FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:TRAPPC11-KCNN4

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: TRAPPC11-KCNN4
FusionPDB ID: 93778
FusionGDB2.0 ID: 93778
HgeneTgene
Gene symbol

TRAPPC11

KCNN4

Gene ID

60684

3783

Gene nametrafficking protein particle complex 11potassium calcium-activated channel subfamily N member 4
SynonymsC4orf41|FOIGR|GRY|LGMD2S|LGMDR18DHS2|IK|IK1|IKCA1|KCA4|KCa3.1|SK4|hIKCa1|hKCa4|hSK4
Cytomap

4q35.1

19q13.31

Type of geneprotein-codingprotein-coding
Descriptiontrafficking protein particle complex subunit 11foie gras homologgryzun homologintermediate conductance calcium-activated potassium channel protein 4SKCa 4SKCa4potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4potassium intermediate/small conductance calcium-activated channel, subfami
Modification date2020031320200329
UniProtAcc

Q7Z392

Main function of 5'-partner protein: FUNCTION: Involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage. {ECO:0000269|PubMed:21525244, ECO:0000269|PubMed:27862579}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000511409, ENST00000334690, 
ENST00000357207, ENST00000512476, 
ENST00000262888, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 7 X 5=2457 X 6 X 6=252
# samples 78
** MAII scorelog2(7/245*10)=-1.8073549220576
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/252*10)=-1.65535182861255
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: TRAPPC11 [Title/Abstract] AND KCNN4 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: TRAPPC11 [Title/Abstract] AND KCNN4 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)TRAPPC11(184589270)-KCNN4(44276287), # samples:2
Anticipated loss of major functional domain due to fusion event.TRAPPC11-KCNN4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
TRAPPC11-KCNN4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneKCNN4

GO:0006816

calcium ion transport

18796614

TgeneKCNN4

GO:0030322

stabilization of membrane potential

18796614

TgeneKCNN4

GO:0050862

positive regulation of T cell receptor signaling pathway

18796614



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr4:184589270/chr19:44276287)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across TRAPPC11 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KCNN4 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000334690TRAPPC11chr4184589270+ENST00000262888KCNN4chr1944276287-1923762101362450
ENST00000357207TRAPPC11chr4184589270+ENST00000262888KCNN4chr1944276287-1897736321336434

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000334690ENST00000262888TRAPPC11chr4184589270+KCNN4chr1944276287-0.0080278960.9919721
ENST00000357207ENST00000262888TRAPPC11chr4184589270+KCNN4chr1944276287-0.0086705160.99132943

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for TRAPPC11-KCNN4

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
TRAPPC11chr4184589270KCNN4chr1944276287736234VLPHTDHLVGYIIRQAVNATGHLSDT
TRAPPC11chr4184589270KCNN4chr1944276287762250VLPHTDHLVGYIIRQAVNATGHLSDT

Top

Potential FusionNeoAntigen Information of TRAPPC11-KCNN4 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TRAPPC11-KCNN4_184589270_44276287.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TRAPPC11-KCNN4chr4184589270chr1944276287762HLA-B52:01VGYIIRQAV0.95630.8235817

Top

Potential FusionNeoAntigen Information of TRAPPC11-KCNN4 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
TRAPPC11-KCNN4_184589270_44276287.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0103LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0103VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0403GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0403VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0413GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0413VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0413LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0415GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0415VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0415LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0427GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0427VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0427LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0436GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0436VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0436LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0437GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0439GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0439VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0440GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0440VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0441GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0441VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0444GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0444VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0444LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0446GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0446VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0449GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0449VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0449LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0450GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0450VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0451GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0451VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0451LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0452GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0452VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0453GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0453VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0455GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0455VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0455LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0456GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0456VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0458GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0458VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0458LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0459GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0460GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0460VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0465GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0465VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0468GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0468VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0470GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0470VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0470LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0471GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0471VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0473GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0473VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0473LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0478GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0478VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0478LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0479GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0479VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0485GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0485VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0488GYIIRQAVNATGHLS924
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0488VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-0488LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1367LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1367VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1401DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1401TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1426DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1426TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1435DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1435TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1454DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1454TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1458DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1458TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1460DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1460TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1475DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1475TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1486DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1486TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1487DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1487TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1488DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1488TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1490DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1490TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1497DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1497TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1499DHLVGYIIRQAVNAT520
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB1-1499TDHLVGYIIRQAVNA419
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0101LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0101VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0101HLVGYIIRQAVNATG621
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0103LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0103VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0103HLVGYIIRQAVNATG621
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0104LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0104VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0104HLVGYIIRQAVNATG621
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0106LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0106VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0106HLVGYIIRQAVNATG621
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0107LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0107VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0107HLVGYIIRQAVNATG621
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0108LVGYIIRQAVNATGH722
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0108VGYIIRQAVNATGHL823
TRAPPC11-KCNN4chr4184589270chr1944276287762DRB4-0108HLVGYIIRQAVNATG621

Top

Fusion breakpoint peptide structures of TRAPPC11-KCNN4

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
3418HLVGYIIRQAVNATTRAPPC11KCNN4chr4184589270chr1944276287762

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of TRAPPC11-KCNN4

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN3418HLVGYIIRQAVNAT-8.56775-8.56775
HLA-A11:014UQ23418HLVGYIIRQAVNAT-4.78924-4.78924
HLA-A24:025HGA3418HLVGYIIRQAVNAT-8.52624-8.52624
HLA-B27:056PYJ3418HLVGYIIRQAVNAT-4.52663-4.52663

Top

Vaccine Design for the FusionNeoAntigens of TRAPPC11-KCNN4

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
TRAPPC11-KCNN4chr4184589270chr1944276287817VGYIIRQAVGGGTTATATTATAAGGCAGGCTGTTAA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
TRAPPC11-KCNN4chr4184589270chr1944276287419TDHLVGYIIRQAVNATGACCACCTTGTGGGTTATATTATAAGGCAGGCTGTTAATGCCAC
TRAPPC11-KCNN4chr4184589270chr1944276287520DHLVGYIIRQAVNATCCACCTTGTGGGTTATATTATAAGGCAGGCTGTTAATGCCACTGG
TRAPPC11-KCNN4chr4184589270chr1944276287621HLVGYIIRQAVNATGCCTTGTGGGTTATATTATAAGGCAGGCTGTTAATGCCACTGGGCA
TRAPPC11-KCNN4chr4184589270chr1944276287722LVGYIIRQAVNATGHTGTGGGTTATATTATAAGGCAGGCTGTTAATGCCACTGGGCACCT
TRAPPC11-KCNN4chr4184589270chr1944276287823VGYIIRQAVNATGHLGGGTTATATTATAAGGCAGGCTGTTAATGCCACTGGGCACCTTTC
TRAPPC11-KCNN4chr4184589270chr1944276287924GYIIRQAVNATGHLSTTATATTATAAGGCAGGCTGTTAATGCCACTGGGCACCTTTCAGA

Top

Information of the samples that have these potential fusion neoantigens of TRAPPC11-KCNN4

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECTRAPPC11-KCNN4chr4184589270ENST00000334690chr1944276287ENST00000262888TCGA-EY-A4KR-01A

Top

Potential target of CAR-T therapy development for TRAPPC11-KCNN4

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneKCNN4chr4:184589270chr19:44276287ENST0000026288829241_2610452.6666666666667IntramembranePore-forming%3B Name%3DSegment H5
TgeneKCNN4chr4:184589270chr19:44276287ENST0000026288829265_2850452.6666666666667TransmembraneHelical%3B Name%3DSegment S6

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to TRAPPC11-KCNN4

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to TRAPPC11-KCNN4

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource